Attention Deficit-hyperactivity Disorder; Adhd

Description

A behavior disorder in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity.

Clinical Features

Phenotypes and symptoms related to Attention Deficit-hyperactivity Disorder; Adhd

  • Depressivity
  • Hyperactivity
  • Autism
  • Anxiety
  • Attention deficit hyperactivity disorder
  • Falls
  • Impulsivity
  • Dyslexia

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Attention Deficit-hyperactivity Disorder; Adhd Is also known as hyperactivity of childhood.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Attention Deficit-hyperactivity Disorder; Adhd Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Attention deficit-hyperactivity disorder (sequence analysis of DRD4 gene).

By CGC Genetics (Portugal).

DRD4
Specificity
100 %
Genes
34 %
DRD4.

By Fulgent Genetics Fulgent Genetics (United States).

DRD4
Specificity
100 %
Genes
34 %
MitoMetĀ®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
34 %
MECP2 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

MECP2
Specificity
100 %
Genes
34 %
MECP2 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories (United States).

MECP2
Specificity
100 %
Genes
34 %
MECP2 Deletion/Duplication Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories (United States).

MECP2
Specificity
100 %
Genes
34 %
MECP2 Sequence Analysis.

By Baylor Miraca Genetics Laboratories (United States).

MECP2
Specificity
100 %
Genes
34 %
MECP2 Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories (United States).

MECP2
Specificity
100 %
Genes
34 %

You can get up to 229 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5 VOGT-KOYANAGI-HARADA DISEASE MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1 ISCHIOCOXOPODOPATELLAR SYNDROME; ICPPS SPLIT-HAND/FOOT MALFORMATION 6; SHFM6